Quick Research
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Indonesia
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 29,572 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Construction and application of a humanized mouse model for prostate cancer in immunotherapy (2025-11-18)
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY (2025) IF: 5.1Products Cited: General Freezing Medium -
Development of the rationale of a personalized cancer vaccine based on the in situ vaccine effect of radiotherapy: a mechanistic study of the POLARSTAR trial (2025-11-12)
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY (2025) IF: 5.1Products Cited: CT26.WT Cells Line, HCT 116 Cells Line -
Dissecting the role of SEPHS1 in shaping an immunosuppressive microenvironment to promote tumor progression (2025-12-24)
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY (2025) IF: 5.1Products Cited: DMEM (High glucose) Medium, Heat Inactivated Fetal Bovine Serum -
FUBP3 mediates MXI1 stability to silence RRAS and hinder MAPK signaling in acute megakaryoblastic leukemia progression (2025-12-22)
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY (2025) IF: 5.1Products Cited: Penicillin-Streptomycin-Amphotericin B Solution, 100 ×, M-07e Cells Line, DMEM (High glucose) Complete Medium (10), Human Peripheral Blood Monocyte Complete Medium, MEG-01 Cells Line, Human Peripheral Blood Monocytes, DMEM (High glucose) Complete Medium (20), GM-CSF/CSF2/CSF, Human, Recombinant -
SLC16A3 in lung adenocarcinoma regulates glycolysis and lactate release to facilitate M2 polarization of tumor-associated macrophages (2025-12-23)
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY (2025) IF: 5.1Products Cited: HBE135-E6E7 Cell Complete Medium, HBE135-E6E7 Cells Line, DMEM (High glucose) Medium, NCI-H1792 Cells Line, THP-1 Cells Line, NCI-H1693 Cells Line, RPMI-1640 Medium, NCI-H1975 Cells Line, LLC Cells Line -
Ultrasonic-assisted green synthesis and characterization of nano-hydroxyapatite from Cirrhinus molitorella fish scales bio-waste for biomedical applications (2025-02-18)
Journal: CERAMICS INTERNATIONAL (2025) IF: 5.1Products Cited: MG-63 Cells Line -
3D printed multi-elemental bioceramics induces favorable osteoimmunomodulation for osteogenesis (2025-03-05)
Journal: CERAMICS INTERNATIONAL (2025) IF: 5.1Products Cited: RAW 264.7 Cells Line -
Multi-crosslinked network magnesium phosphate bone cement with high flexural properties (2025-05-17)
Journal: CERAMICS INTERNATIONAL (2025) IF: 5.1Products Cited: Rat Osteoblast Cells -
Synergistic Anticancer Enhancement: Sericin Nanogels Co-Delivery of C3G and Cancer Drugs Irinotecan, Paclitaxel, and Oxaliplatin (2025-06-04)
Journal: Food Hydrocolloids for Health (2025) IF: 5.1Products Cited: Mouse Hepatic Sinusoidal Endothelial Cells, Hela Cells Line, 293T [HEK-293T] Cells Line -
STC1 promotes paclitaxel resistance in oral squamous cell carcinoma by inhibiting oxidative stress via activating the JAK/STAT signaling pathway (2025-06-03)
Journal: LIFE SCIENCES (2025) IF: 5.1Products Cited: DMEM (High glucose) Medium
